Oslo biotech finds another merger partner after shareholders rejected November offer
2023-06-09
并购
Shareholders of Nordic NanovectorNanovector did not like the first merger partner the Norwegian biotech chose last fall. So the company went back to the drawing board and has found a new one: Thor Medical.
Nordic Nanovector had originally planned to
combine with APIM Therapeutics
, but a few weeks after the November disclosure, shareholders decided it was a no-go.
This time around, Nordic Nanovector hopes to combine with the small, private Thor Medical, which is working on proprietary tech to make radionuclides, including alpha-particle emitters that it plans to supply to radiopharma companies for cancer therapeutics. By its count, more than 50 such startups and biopharma companies are working on cancer radiotherapy, and it expects to make a final decision on an industrial-scale manufacturing facility in 2025.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-药物
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。